Palatin Technologies, Inc. revenue for the last year amounted to 4.49 M USD, the most of which — 4.49 M USD — came from its highest performing source at the moment, Melanocortin Receptor System, the year earlier bringing 4.85 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Palatin Technologies, Inc. 4.49 M USD, and the year before that — 4.85 M USD.